Life Technologies Corp (LIFE): Today's Featured Health Care Loser

Life Technologies ( LIFE) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.4%. By the end of trading, Life Technologies fell 65 cents (-1.4%) to $45.64 on heavy volume. Throughout the day, 2.7 million shares of Life Technologies exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in price between $45.25-$47 after having opened the day at $46.93 as compared to the previous trading day's close of $46.29. Other company's within the Health Care sector that declined today were: Idera Pharmaceuticals ( IDRA), down 20.3%, NeurogesX ( NGSX), down 10.8%, Chemocentryx ( CCXI), down 8.5%, and Anthera Pharmaceuticals ( ANTH), down 7.5%.

Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.2 billion and is part of the health services industry. The company has a P/E ratio of 22.4, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 19% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Life Technologies a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, Medgenics ( MDGN), up 23.5%, Amyris ( AMRS), up 19.2%, Kindred Healthcare ( KND), up 18.8%, and Accelr8 Technology Corporation ( AXK), up 18.1%, were all gainers within the health care sector with Bristol-Myers Squibb Company ( BMY) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Component Stocks Rise After Trump Reverses Decision on ZTE

Component Stocks Rise After Trump Reverses Decision on ZTE